Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication

Digestion

Volumn 78, Issue 2-3, 2008, Pages 113-119

  Shiotani, Akiko ^a,c   Uedo, Noriya ^b   Iishi, Hiroyasu ^b   Yoshiyuki, Yamanaka ^a   Ishii, Manabu ^a   Manabe, Noriaki ^a   Kamada, Tomoari ^a   Kusunoki, Hiroaki ^a   Hata, Jiro ^a   Haruma, Ken ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c NONE   (Japan)

Author keywords

Atrophic gastritis; Gastric cancer; Helicobacter pylori eradication; Pepsinogen; Screening

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; GASTRIN 17; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PEPSINOGEN I; PEPSINOGEN II; PROTON PUMP INHIBITOR; RABEPRAZOLE;

AGED; ARTICLE; ATROPHY; BLOOD SAMPLING; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; DRUG ERUPTION; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTRIN BLOOD LEVEL; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUCOSA; PREDICTOR VARIABLE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STOMACH CANCER;

FEMALE; HELICOBACTER INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PEPSINOGEN A; PEPSINOGEN C; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 56349154145     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000173719     Document Type: Article

References (26)

1. Meining A, Morgner A, Miehlke S, Bayerdorffer E, Stolte M: Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis? Best Pract Res Clin Gastroenterol 2001;15:983-998.
2. Dixon MF: Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia. Gut 2001;49:2-4.
3. Correa P: Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19(suppl 1):S37-S43.
4. Shiotani A, Iishi H, Uedo N, Kumamoto M, Nakae Y, Ishiguro S, Tatsuta M, Graham DY: Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer 2005;115:463-469.
5. Graham DY: Helicobacter pylori infection is the primary cause of gastric cancer. J Gastroenterol 2000;35(suppl 12):90-97.
6. Correa P: Chronic gastritis as a cancer precursor. Scand J Gastroenterol Suppl 1984;104:131-136.
7. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
8. Shiotani A, Iishi H, Uedo N, Higashino K, Kumamoto M, Nakae Y, Tatsuta M: Hypoacidity combined with high gastric juice nitrite induced by Helicobacter pylori infection is associated with gastric cancer. Aliment Pharmacol Ther 2004;20(suppl 1):48-53.
9. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK: Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187-194.
10. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K, Okada H, Shiratori Y: The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol 2005;100:1037-1042.
11. Japanese Classification of Gastric Carcinoma, 2nd Engl Ed: Response assessment of chemotherapy and radiotherapy for gastric carcinoma: clinical criteria. Gastric Cancer 2001;4:1-8.
12. Shiotani A, Uedo N, Iishi H, Tatsuta M, Ishiguro S, Nakae Y, Kamada T, Haruma K, Merchant JL: Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia. Int J Cancer 2007;121:1182-1189.
13. Uedo N, Ishihara R, Iishi H, Yamamoto S, Yamamoto S, Yamada T, Imanaka K, Takeuchi Y, Higashino K, Ishiguro S, Tatsuta M: A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy 2006;38:819-824.
14. Uedo N, Iishi H, Tatsuta M, Yamada T, Ogiyama H, Imanaka K, Sugimoto N, Higashino K, Ishihara R, Narahara H, Ishiguro S: A novel videoendoscopy system by using autofluorescence and reflectance imaging for diagnosis of esophagogastric cancers. Gastrointest Endosc 2005;62:521-528.
15. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-1181.
16. Kimura K: Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972;63:584-592.
17. Kimura K, Satoh K, Ido K, Taniguchi Y, Takimoto T, Takemoto T: Gastritis in the Japanese stomach. Scand J Gastroenterol Suppl 1996;214:17-20.
18. Shiotani A, Haruma K, Uedo N, Iishi H, Ishihara R, Tatsuta M, Kumamoto M, Nakae Y, Ishiguro S, Graham DY: Histological risk markers for non-cardia early gastric cancer: Pattern of mucin expression and gastric cancer. Virchows Arch 2006;449:652-659.
19. Shiotani A, Iishi H, Uedo N, Ishiguro S, Tatsuta M, Nakae Y, Kumamoto M, Merchant JL: Evidence that loss of sonic hedgehog is an indicator of Helicobacter pylori -induced atrophic gastritis progressing to gastric cancer. Am J Gastroenterol 2005;100:581-587.
20. Graham DY, Shiotani A: The time to eradicate gastric cancer is now. Gut 2005;54:735-738.
21. Sipponen P, Kimura K: Intestinal metaplasia, atrophic gastritis and stomach cancer: trends over time. Eur J Gastroenterol Hepatol 1994;6(suppl 1):S79-S83.
22. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, Sasaki N, Haruma K, Sumii K, Kajiyama G: Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997;6:639-642.
23. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M: Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an openlabel, randomised controlled trial. Lancet 2008;372:392-397.
24. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K: Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. J Gastroenterol 2007;42(suppl 17):21-27.
25. Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, Lau JY, Sung JJ: Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 2004;53:1244-1249.
26. Graham DY, Uemura N: Natural history of gastric cancer after Helicobacter pylori eradication in Japan: after endoscopic resection, after treatment of the general population, and naturally. Helicobacter 2006;11:139-143.